Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Apollo Endosurgery Inc (NQ: APEN ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Apr 3, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Apollo Endosurgery Inc < Previous 1 2 Next > Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity December 13, 2022 Via ACCESSWIRE BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT) December 05, 2022 From Brodsky & Smith LLC Via GlobeNewswire APOLLO ENDOSURGERY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apollo Endosurgery, Inc. - APEN November 29, 2022 From Kahn Swick & Foti, LLC Via Business Wire Apollo Endosurgery to be Acquired by Boston Scientific November 29, 2022 Via ACCESSWIRE Apollo Endosurgery, Inc. Reports Record $19.6 million Global Revenue in Third Quarter 2022 November 01, 2022 Via ACCESSWIRE Endoscopic Sleeve Gastroplasty (ESG) Procedure Featured as a "Top 10" Paper at the IFSO 2022 World Congress in Miami August 31, 2022 Via ACCESSWIRE Apollo Endosurgery (NASDAQ: APEN) Enters Into Agreement to be Acquired by Boston Scientific (NYSE: BSX) for $615 Million November 29, 2022 Apollo Endosurgery, Inc. (NASDAQ: APEN) is a medical technology company, which is focused on the research and development of advanced, Via Spotlight Growth Exposures Product Safety APEN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Apollo Endosurgery, Inc. Is Fair to Shareholders November 29, 2022 From Halper Sadeh LLC Via Business Wire Apollo Endosurgery Completes Transition to European MDR Requirements for the OverStitch Systems, BIB and Orbera 365 intragastric balloons, and OverTube. November 21, 2022 Via ACCESSWIRE Apollo Endosurgery to Participate in Upcoming Investor Conferences November 07, 2022 Via ACCESSWIRE Apollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022 August 02, 2022 Via ACCESSWIRE Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure July 29, 2022 Via ACCESSWIRE Apollo Endosurgery to Report Third Quarter Results on November 1, 2022 October 18, 2022 Via ACCESSWIRE Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure July 29, 2022 Publication of MERIT Study Follows FDA Market Authorization of Apollo ESG™ From Apollo Endosurgery, Inc. Via AccessWire Exposures Product Safety Apollo Endosurgery to Report Second Quarter Results on August 2, 2022 July 21, 2022 Via ACCESSWIRE Apollo Endosurgery to Report Second Quarter Results on August 2, 2022 July 21, 2022 AUSTIN, TX / ACCESSWIRE / July 21, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and... From Apollo Endosurgery, Inc. Via AccessWire FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity July 13, 2022 Systems Offer Effective, Minimally Invasive Treatment Options for Millions of Patients with Obesity (BMI 30-50 kg/m2) From Apollo Endosurgery, Inc. Via AccessWire Exposures Product Safety FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG and Apollo REVISE, New Endoscopic Systems for Patients with Obesity July 13, 2022 Via ACN Newswire Exposures Product Safety Sharon O'Keefe Joins Apollo Endosurgery Board of Directors July 06, 2022 Seasoned healthcare leader brings 30 years of hospital system and medical technology expertise From Apollo Endosurgery, Inc. Via AccessWire Digestive Disease Week 2022 Adds to the Growing Wave of Clinical Evidence Supporting Significant Opportunity for Apollo Endosurgery Products May 31, 2022 AUSTIN, TX / ACCESSWIRE / May 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,... From Apollo Endosurgery, Inc. Via AccessWire Apollo Endosurgery Products to Take Center Stage at Digestive Disease Week May 18, 2022 AUSTIN, TX / ACCESSWIRE / May 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,... From Apollo Endosurgery, Inc. Via AccessWire Apollo Endosurgery, Inc. Reports 33% U.S. Revenue Growth in First Quarter 2022 May 03, 2022 Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. From Apollo Endosurgery, Inc. Via AccessWire Apollo Endosurgery to Report First Quarter Results on May 3, 2022 April 13, 2022 AUSTIN, TX / ACCESSWIRE / April 13, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (Nasdaq:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and... From Apollo Endosurgery, Inc. Via AccessWire Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors April 04, 2022 Veteran Brings 30 Years of Multinational Healthcare Leadership Experience AUSTIN, TX / ACCESSWIRE / April 4, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally... From Apollo Endosurgery, Inc. Via AccessWire Apollo Endosurgery to Participate in the Cowen Healthcare Conference March 02, 2022 AUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today... From Apollo Endosurgery, Inc. Via AccessWire Apollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021 February 22, 2022 - Increased adoption across all product lines in both U.S. and international - Grew fourth quarter 2021 revenue 26% AUSTIN, TX / ACCESSWIRE / February 22, 2022 / Apollo Endosurgery, Inc. ("Apollo")... From Apollo Endosurgery, Inc. Via AccessWire Apollo Endosurgery to Report Fourth Quarter and Full Year Results on February 22, 2022 February 10, 2022 AUSTIN, TX / ACCESSWIRE / February 10, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal... From Apollo Endosurgery, Inc. Via AccessWire Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access January 18, 2022 Veteran Leader Brings 25 Years of Global Medical Device Experience AUSTIN, TX / ACCESSWIRE / January 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive... From Apollo Endosurgery, Inc. Via AccessWire Apollo Endosurgery Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020 January 10, 2022 Fourth quarter 2021 revenue grew 25% over 2020 AUSTIN, TX / ACCESSWIRE / January 10, 2022 / Apollo Endosurgery, Inc. ("Apollo" or the "Company") (NASDAQ:APEN), a global leader in less invasive medical... From Apollo Endosurgery, Inc. Via AccessWire Apollo Endosurgery Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLC December 21, 2021 - $35 million funded at close to refinance existing debt, extend maturity and lower interest expense - Additional borrowing capacity provides minimally dilutive growth capital and strategic flexibility... From Apollo Endosurgery, Inc. Via AccessWire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.